Children with sickle cell disease (SCD) were shown to have annual medical costs of $9369 (Medicaid) and $13,469 (private insurance), which is significantly higher than that for children without SCD, according to a study led by Djesika D. Amendah, PhD, an economist at the CDC.1 SCD in children resulted in total medical costs of at least $335 million per year in the United States in 2005.
Children with sickle cell disease (SCD) were shown to have annual medical costs of $9369 (Medicaid) and $13,469 (private insurance), which is significantly higher than that for children without SCD,
according to a study led by Djesika D. Amendah, PhD, an economist at the CDC.1 SCD in children resulted in total medical costs of at least $335 million per year in the United States in 2005.
Children with SCD enrolled in Medicaid were shown to have lower medical costs than those with private insurance ($14,722, private insurance; $11,075, Medicaid [Figure]). However, annual average costs of prescription drugs were lower for children with SCD who had private insurance ($531) than they were for those enrolled in Medicaid ($1049).
Reference
1. Amendah DD, Mvundura M, Kavanagh PL, et al. Sickle cell disease-related pediatric medical expenditures in the US. Am J Prev Med. 2010;38(suppl 4):S550-S556.
2024 PatientPoint Patient Confidence Index
August 30th 2024In our 2024 PatientPoint Patient Confidence Index, we surveyed 2,000 Americans to understand their views on doctor visits and the healthcare industry. This report reveals insights to help providers better understand the patient experience and engage in meaningful patient conversations. Key insights include: 81% of patients trust their doctor, with 33% noting increased trust over the past year. 66% feel heard and respected by their doctor. 20% decrease in patients feeling confused after appointments in the last two years. Download the report to get access to this year’s insights.